blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1618890

EP1618890 - Use of antibodies in a very low dose for the vaccination against cancer [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  11.01.2013
Database last updated on 26.06.2024
Most recent event   Tooltip17.04.2020Lapse of the patent in a contracting state
New state(s): CY		published on 20.05.2020  [2020/21]
Applicant(s)For all designated states
Altropus GmbH
Mattenhofweg 4
4144 Arlesheim / CH
[N/P]
Former [2007/21]For all designated states
ALTROPUS GMBH
Mattenhofweg 4
4144 Arlesheim / CH
Former [2006/04]For all designated states
Igeneon Krebs-Immuntherapie Forschungs- und Entwicklungs-AG
Brunner Strasse 69, Objekt 3
1230 Wien / AT
Inventor(s)01 / Loibner, Hans
Heimgasse 23
1238 Vienna / AT
02 / Himmler, Gottfried
Colloredogasse 29
1180 Vienna / AT
03 / Schuster, Manfred
Josef Weilandstrasse 84
2191 Schrick / AT
 [2006/04]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2006/04]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date04450149.220.07.2004
[2006/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1618890
Date:25.01.2006
Language:EN
[2006/04]
Type: B1 Patent specification 
No.:EP1618890
Date:06.10.2010
Language:EN
[2010/40]
Search report(s)(Supplementary) European search report - dispatched on:EP25.11.2004
ClassificationIPC:A61K39/395, A61K39/39, A61P35/00, C07K16/30
[2006/04]
CPC:
C07K16/30 (EP,US); A61P35/00 (EP); A61K2039/505 (EP,US);
A61K2039/545 (EP,US); A61K2039/55505 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/04]
TitleGerman:Verwendung von Antikörpern in einer sehr geringen Dosis zur Impfung gegen Krebs[2006/04]
English:Use of antibodies in a very low dose for the vaccination against cancer[2006/04]
French:Utilisation d'anticorps en très faibles doses pour vaccination contre le cancer[2006/04]
Examination procedure25.07.2006Examination requested  [2006/36]
07.09.2006Despatch of a communication from the examining division (Time limit: M08)
21.06.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
21.08.2007Reply to a communication from the examining division
27.04.2010Communication of intention to grant the patent
18.08.2010Fee for grant paid
18.08.2010Fee for publishing/printing paid
Opposition(s)Opponent(s)01  05.07.2011    ADMISSIBLE
Fresenius Biotech GmbH
Frankfurter Ring 193a
80807 München / DE
Opponent's representative
Wichmann, Hendrik, et al, et al
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstraße 2
81541 München / DE
 [N/P]
Former [2011/32]
Opponent(s)01  05.07.2011    ADMISSIBLE
Fresenius Biotech GmbH
Frankfurter Ring 193a
80807 München / DE
Opponent's representative
Wichmann, Hendrik, et al, et al
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstraße 2
DE-81541 München / DE
09.08.2011Invitation to proprietor to file observations on the notice of opposition
19.12.2011Reply of patent proprietor to notice(s) of opposition
11.09.2012Cancellation of oral proceeding that was planned for 02.10.2012
25.09.2012Despatch of communication that the patent will be revoked
02.10.2012Date of oral proceedings
05.10.2012Legal effect of revocation of patent [2013/07]
Request for further processing for:21.08.2007Request for further processing filed
22.08.2007Full payment received (date of receipt of payment)
Request granted
06.09.2007Decision despatched
Fees paidRenewal fee
25.07.2006Renewal fee patent year 03
10.07.2007Renewal fee patent year 04
10.07.2008Renewal fee patent year 05
30.07.2009Renewal fee patent year 06
10.07.2010Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE06.10.2010
CH06.10.2010
CY06.10.2010
CZ06.10.2010
DK06.10.2010
EE06.10.2010
FI06.10.2010
HU06.10.2010
IT06.10.2010
LI06.10.2010
PL06.10.2010
RO06.10.2010
SE06.10.2010
SI06.10.2010
SK06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
LU20.07.2011
MC31.07.2011
[2020/21]
Former [2014/27]BE06.10.2010
CH06.10.2010
CZ06.10.2010
DK06.10.2010
EE06.10.2010
FI06.10.2010
HU06.10.2010
IT06.10.2010
LI06.10.2010
PL06.10.2010
RO06.10.2010
SE06.10.2010
SI06.10.2010
SK06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
LU20.07.2011
MC31.07.2011
Former [2014/20]BE06.10.2010
CH06.10.2010
CZ06.10.2010
DK06.10.2010
EE06.10.2010
FI06.10.2010
HU06.10.2010
IT06.10.2010
LI06.10.2010
PL06.10.2010
RO06.10.2010
SE06.10.2010
SI06.10.2010
SK06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
MC31.07.2011
Former [2013/20]BE06.10.2010
CH06.10.2010
CZ06.10.2010
DK06.10.2010
EE06.10.2010
FI06.10.2010
IT06.10.2010
LI06.10.2010
PL06.10.2010
RO06.10.2010
SE06.10.2010
SI06.10.2010
SK06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
MC31.07.2011
Former [2011/35]BE06.10.2010
CZ06.10.2010
EE06.10.2010
FI06.10.2010
SE06.10.2010
SI06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
Former [2011/32]BE06.10.2010
FI06.10.2010
SE06.10.2010
SI06.10.2010
BG06.01.2011
GR07.01.2011
ES17.01.2011
PT07.02.2011
Former [2011/24]FI06.10.2010
SE06.10.2010
SI06.10.2010
PT07.02.2011
Former [2011/10]SI06.10.2010
Documents cited:Search[X]WO0041722  (IGENEON GMBH [AT], et al) [X] 1-12 * the whole document *;
 [X]EP1140168  (IGENEON KREBS IMMUNTHERAPIE [AT]) [X] 1-12* the whole document *;
 [X]EP1230932  (IGENEON KREBS IMMUNTHERAPIE [AT]) [X] 1-12 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.